Risk-Reward Balanced at Molina - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 4:35PM CDT
On April 16, 2014, we issued an updated research report on Molina Healthcare Inc.
UnitedHealth Beats on Q1 Earnings, Lags Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 10:10AM CDT
U.S. health insurer UnitedHealth Group Inc. reported first-quarter 2014 operating earnings of $1.10 per share
MEDNAX 2014 First Quarter Conference Call/Webcast Scheduled for Thursday, May 1, 2014
Business Wire - Wed Apr 16, 6:00AM CDT
MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Thursday, May 1, 2014 at 10:00 a.m. EDT, to discuss results from operations for the three months ended March 31, 2014. A detailed press release will be issued the morning of May 1, 2014 before the securities markets open.
Risk-Reward Balanced at DaVita - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 9:10AM CDT
On April 10, 2014, we issued an updated research report on DaVita Healthcare Partners Inc.
Shares of MD Up 13.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 08, 5:06PM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on January 15th, 2014 at $54.57. In approximately 3 months, Mednax has returned 13.31% as of today's recent price of $61.83.
Updated Research Report on Tenet Healthcare - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 9:40AM CDT
On April 3, 2014, we issued an updated research report on Tenet Healthcare Corp.
MEDNAX Names Charles Lynch Vice President, Strategy and Investor Relations
Business Wire - Fri Apr 04, 6:00AM CDT
MEDNAX, Inc., (NYSE: MD) today announced that it has named Charles Lynch Vice President, Strategy and Investor Relations.
WellCare: A Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 4:20PM CDT
On April 1, Zacks Investment Research downgraded WellCare to a Zacks Rank #5 (Strong Sell).
Mednax Has Returned 18.1% Since SmarTrend Recommendation (MD)
Comtex SmarTrend(R) - Tue Apr 01, 11:08AM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on January 15th, 2014 at $54.57. In approximately 3 months, Mednax has returned 18.12% as of today's recent price of $64.45.
WellPoint Upgraded to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 9:20AM CDT
Zacks Investment Research upgraded WellPoint Inc. to a Zacks Rank #2 (Buy) on April 1, 2014.
Will This Upgrade Help Mednax (MD) Today
at The Street - Tue Apr 01, 8:17AM CDT
Deutsche Bank upgrades Mednax (MD) to 'buy' from 'hold,' and raises its price target to $73 from $57, saying the company can deliver high organic growth.
Upgrade Alert for Mednax (MD)
Comtex SmarTrend(R) - Tue Apr 01, 6:59AM CDT
Mednax (NYSE:MD) was upgraded from Hold to Buy at Deutsche Bank today. The stock closed yesterday at $61.98 on volume of 558,000 shares, below average daily volume of 583,000. MEDNAX, Inc., through a subsidiary, provides physician management services to hospital-based neonatal, maternal - fetal, pediatric cardiology, and pediatric intensive care specialties. The Company also manages anesthesia practices.
Health Care Equities Technical Momentum -- Research on Laboratory Corp. of America, Omnicare, DaVita HealthCare Partners, and MEDNAX
PR Newswire - Fri Mar 28, 9:17AM CDT
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at 16,268.99, and the S&P 500 ended the day at 1,852.56, down 0.70%. The losses were broad based with nine out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 672.05, up 0.05%, and the same has gained 4.63% in the last three months. Investor-Edge has initiated coverage on the following equities: Laboratory Corp. of America Holdings (NYSE: LH), Omnicare Inc. (NYSE: OCR), DaVita HealthCare Partners Inc. (NYSE: DVA), and MEDNAX Inc. (NYSE: MD). Free technical research on LH, OCR, DVA, and MD can be downloaded upon signing up at:
Recognitions, Board Elections, Acquisitions, and Organizational Changes - Analyst Notes on Omnicare, Cooper, Mednax, IDEXX, and Hologic
PR Newswire - Thu Mar 27, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Omnicare Inc. (NYSE: OCR), The Cooper Companies Inc. (NYSE: COO), MEDNAX, Inc. (NYSE: MD), IDEXX Laboratories, Inc. (NASDAQ: IDXX), and Hologic Inc. (NASDAQ: HOLX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Uptrend Call Working As Mednax Stock Rises 15.3% (MD)
Comtex SmarTrend(R) - Tue Mar 18, 9:14AM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on January 15th, 2014 at $54.57. In approximately 2 months, Mednax has returned 15.26% as of today's recent price of $62.89.
MEDNAX Announces Acquisition of Neonatology Practice in North Carolina
Business Wire - Tue Mar 04, 6:00AM CST
MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Piedmont Neonatology, P.C., a private neonatal physician group practice based in Greensboro, N.C. The practice will become part of MEDNAX's Pediatrix Medical Group division, a national group practice consisting of the nation's leading neonatal, maternal-fetal medicine, pediatric cardiology, and other pediatric specialty physicians.